What question did this study set out to answer?

This research aims to explore the prognosis and treatment implications of POLE mutations in endometrial cancer.

February 25, 2026Open Access

Promising survival prospects and immunotherapy potential in POLE-mutated endometrial cancer: a comprehensive systematic review and meta-analysis unveiling future therapeutic opportunities

Key Points

This research aims to explore the prognosis and treatment implications of POLE mutations in endometrial cancer.
Conducted a systematic review of existing literature on POLE mutations in endometrial cancer.
Performed a meta-analysis to evaluate survival rates associated with POLE mutations.
Assessed the potential of immunotherapy for patients with POLE-mutated endometrial cancer.
POLE mutations correlate with better survival outcomes in endometrial cancer.
Immunotherapy shows significant promise as a treatment for POLE-mutated cases.
Molecular subtyping that includes POLE mutation status enhances risk stratification and treatment planning.

Abstract

POLE mutations in endometrial cancer are associated with a favorable prognosis and show promising potential for immunotherapy. Molecular subtyping that incorporates POLE mutation status should be considered standard practice for risk stratification and treatment planning.

Bookmark

View Full Paper

Cite This Study

Adella et al. (Fri,) studied this question.

synapsesocial.com/papers/699e90eff5123be5ed04e28e https://doi.org/https://doi.org/10.5468/ogs.25179

Bookmark

View Full Paper